198 related articles for article (PubMed ID: 21143603)
1. The influence of oxygen depletion and photosensitizer triplet-state dynamics during photodynamic therapy on accurate singlet oxygen luminescence monitoring and analysis of treatment dose response.
Jarvi MT; Niedre MJ; Patterson MS; Wilson BC
Photochem Photobiol; 2011; 87(1):223-34. PubMed ID: 21143603
[TBL] [Abstract][Full Text] [Related]
2. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
[TBL] [Abstract][Full Text] [Related]
3. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
Dysart JS; Singh G; Patterson MS
Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of singlet oxygen is useful for predicting the photodynamic effects in the treatment for experimental glioma.
Yamamoto J; Yamamoto S; Hirano T; Li S; Koide M; Kohno E; Okada M; Inenaga C; Tokuyama T; Yokota N; Terakawa S; Namba H
Clin Cancer Res; 2006 Dec; 12(23):7132-9. PubMed ID: 17145838
[TBL] [Abstract][Full Text] [Related]
5. Insights into photodynamic therapy dosimetry: simultaneous singlet oxygen luminescence and photosensitizer photobleaching measurements.
Jarvi MT; Patterson MS; Wilson BC
Biophys J; 2012 Feb; 102(3):661-71. PubMed ID: 22325290
[TBL] [Abstract][Full Text] [Related]
6. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.
Mitra S; Foster TH
Photochem Photobiol; 2005; 81(4):849-59. PubMed ID: 15807635
[TBL] [Abstract][Full Text] [Related]
7. Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.
Wang HW; Rickter E; Yuan M; Wileyto EP; Glatstein E; Yodh A; Busch TM
Photochem Photobiol; 2007; 83(5):1040-8. PubMed ID: 17880498
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
9. Theoretical and experimental analysis of the luminescence signal of singlet oxygen for different photosensitizers.
Baier J; Fuss T; Pöllmann C; Wiesmann C; Pindl K; Engl R; Baumer D; Maier M; Landthaler M; Bäumler W
J Photochem Photobiol B; 2007 Jun; 87(3):163-73. PubMed ID: 17482831
[TBL] [Abstract][Full Text] [Related]
10. Time-resolved studies of the excited-state dynamics of meso-tetra(hydroxylphenyl)chlorin in solution.
Howe L; Sucheta A; Einarsdóttir O; Zhang JZ
Photochem Photobiol; 1999 Jun; 69(6):617-23. PubMed ID: 10377999
[TBL] [Abstract][Full Text] [Related]
11. The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry.
Woodhams JH; Macrobert AJ; Bown SG
Photochem Photobiol Sci; 2007 Dec; 6(12):1246-56. PubMed ID: 18046479
[TBL] [Abstract][Full Text] [Related]
12. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
14. In vivo singlet molecular oxygen measurements: Sensitive to changes in oxygen saturation during PDT.
Looft A; Pfitzner M; Preuß A; Röder B
Photodiagnosis Photodyn Ther; 2018 Sep; 23():325-330. PubMed ID: 30026074
[TBL] [Abstract][Full Text] [Related]
15. Prospects of in vivo singlet oxygen luminescence monitoring: Kinetics at different locations on living mice.
Pfitzner M; Schlothauer JC; Bastien E; Hackbarth S; Bezdetnaya L; Lassalle HP; Röder B
Photodiagnosis Photodyn Ther; 2016 Jun; 14():204-10. PubMed ID: 26987416
[TBL] [Abstract][Full Text] [Related]
16. In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy.
Niedre MJ; Secord AJ; Patterson MS; Wilson BC
Cancer Res; 2003 Nov; 63(22):7986-94. PubMed ID: 14633731
[TBL] [Abstract][Full Text] [Related]
17. Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy.
Yuan J; Mahama-Relue PA; Fournier RL; Hampton JA
Radiat Res; 1997 Oct; 148(4):386-94. PubMed ID: 9339955
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals.
Wang KK; Mitra S; Foster TH
Med Phys; 2008 Aug; 35(8):3518-26. PubMed ID: 18777912
[TBL] [Abstract][Full Text] [Related]
19. Photophysical evaluation of mTHPC-loaded HSA nanoparticles as novel PDT delivery systems.
Chen K; Wacker M; Hackbarth S; Ludwig C; Langer K; Röder B
J Photochem Photobiol B; 2010 Dec; 101(3):340-7. PubMed ID: 20813540
[TBL] [Abstract][Full Text] [Related]
20. Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties.
Wacker M; Chen K; Preuss A; Possemeyer K; Roeder B; Langer K
Int J Pharm; 2010 Jun; 393(1-2):253-62. PubMed ID: 20417701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
